Retraction Note: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells.

Cancer Gene Ther

Laboratory Medicine Department, Sheng Jing Hospital of China Medical University, 36 Sanhao St, Heping Qu, 110003, Shenyang, China.

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41417-024-00787-3DOI Listing

Publication Analysis

Top Keywords

retraction note
4
note mir-182
4
mir-182 regulates
4
regulates trastuzumab
4
trastuzumab resistance
4
resistance targeting
4
targeting met
4
met breast
4
breast cancer
4
cancer cells
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!